Astellas Pharma Inc logo

Astellas Pharma Inc

ALPMF · OTC · Pharmaceuticals, Biotech · Founded 1923

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Current Price
—
Market Cap
—
Return Since Last Split
+98%
Last Split
Mar 27, 2014
Total Splits
1
Cumulative Multiple
5×

What If You Bought ALPMF Earlier?

Investment
Purchase Date (Before Split)
Worth Today
—
500 shares · 5×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Mar 27, 2014$11.575-for-15×5×

Astellas Pharma Inc Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Astellas Pharma Inc's latest record in the split calendar is a 5-for-1 forward split effective 2014-03-27.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.